NCT03594058 · Interventional trial
A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)
Overall registry status Completed
Phase 2
Conditions Overactive Bladder
Delaware Valley sites
- Velicept Investigative Site - Lansdale · Lansdale, PA · Montgomery County
First posted
Registry updated
Added to the directory